我的位置: 首页» 科研成果
论文信息：Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains. Jiyuan Liu#, Huanqin Dai#, Bo Wang, Hongwei Liu*, Zhen Tian*, Yalin Zhang*, European Journal of Medicinal Chemistry. 227 (2022) 113932.
JCR分区Q1，中科院大类一区，TOP期刊， IF: 6.514，
论文摘要：As an anti-tuberculosis target, DprE1 contains two flexible loops (Loop I and Loop II) which have never been exploited for developing DprE1 inhibitors. Here Leu317 in Loop II was discovered as a new functional site to combat drug-resistance in Mycobacterium strains. Based on TCA1, LZDT1 was designed to optimize the hydrophobic interaction with Leu317. A subsequent biochemical and cellular assay displayed increased potency of LZDT1 in inhibiting DprE1 and killing drug-sensitive/-resistant Mycobacterium strains. The improved activity of LZDT1 and its analogue LZDT2 against multidrug resistant tuberculosis was particularly highlighted. For LZDT1, its enhanced interaction with Leu317 also impaired the drug-insensitivity of DprE1 caused by Cys387 mutation. A new nonbenzothiazole lead (LZDT10) with reduced Cys387-dependence was further produced by optimizing interactions with Leu317, improvement directions for LZDT10 were discussed as well. Our research underscores the value of potential functional sites in disordered loops, and affords a feasible way to develop these functional sites into opportunities for drug-resistance management.